Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flonoltinib Maleate in healthy volunteers
NCT06387966Phase 1Completed
- Sponsor
- Zenitar
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing Flonoltinib Maleate Treatment Group with Placebo Group (2 arms). Primary endpoints: Time to Maximum Plasma Concentration, Maximum Plasma Concentration and 8 more. Started Mar 2024; status: completed.
02
Drugs
flonoltinib
Beyond the preview
Go deeper on NCT06387966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06387966.